Page 147 - 2021 IDMT Digital
P. 147

REACTIVE LYMPHADENITIS
          Introduction:
            •  5HDFWLYH O\PSKDGHQLWLV RFFXUV ZKHQ D SDWLHQW LV H[SRVHG WR D GLVHDVH SURFHVV ZKLFK
               DIIHFWV WKH O\PSKDWLF V\VWHP
            •  5HDFWLYH O\PSKDGHQLWLV LV D FRPPRQ  DQG XVXDOO\ EHQLJQ  SUREOHP DVVRFLDWHG ZLWK 85,
          Subjective:
            •  6LJQV DQG 6\PSWRPV
                 o  0D\ RU PD\ QRW EH SDLQIXO
                 o  ³6ZROOHQ JODQGV´
                 o  85, W\SH V\PSWRPV
            •  )RFXVHG +LVWRU\
                 o  5HFHQW LOOQHVV
                 o  )HYHU
                 o  )DPLO\ KLVWRU\ RI FDQFHU
                 o  5HFHQW FDW VFUDWFK
                 o  /HQJWK RI WLPH QRGH KDV EHHQ VZROOHQ
          Objective:
            •  3K\VLFDO ([DP
                 o  9LWDO VLJQV   DVVHVV IRU IHYHU
                 o  +((17 H[DP IRU HYLGHQFH RI 85, RU RWKHU SRWHQWLDOO\ FDXVDWLYH DJHQW
                 o  *HQHUDOL]HG O\PSK QRGH H[DP
                 o  (QODUJHG QRGH LV GHILQHG DV !  FP LQ GLDPHWHU
                 o  1RGH PD\ EH UXEEHU\  ERJJ\ RU KDUG
            •  7RROV
                 o  &RQVLGHU ODEV LI QRGH UHPDLQV VZROOHQ JUHDWHU WKDQ    GD\V
                       ƒ  &%&   :%& FRXQW PD\ EH YHU\ KLJK RU YHU\ ORZ
          Assessment:
            •  'LIIHUHQWLDO
                 o  85,  DVVRFLDWHG V\PSWRPV
                 o  0RQRQXFOHRVLV  FRQVWLWXWLRQDO V\PSWRPV  DEGRPLQDO SDLQ  H[SRVXUH  ³NLVVLQJ
                    GLVHDVH´
                 o  0DOLJQDQF\  RQH VLGHG PRUH FRQFHUQLQJ IRU FDQFHU
                 o  &DW VFUDWFK IHYHU  KLVWRU\ RI H[SRVXUH WR FDWV
                 o  +,9  JOREDO O\PSKDGHQRSDWK\
          Plan:
            •  7UHDW WKH FDXVH LI NQRZQ
            •  0HGLFDWLRQV
                 o  &RQVLGHU DQWLELRWLFV IRU LQIHFWLRXV FDXVHV
                 o  &RQVLGHU FRYHUDJH IRU 056$

















                                         [ 146 ]
   142   143   144   145   146   147   148   149   150   151   152